查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1736694

按产品类型、性别、血管类型、应用、区域范围和预测分類的内视镜血管采集系统的全球市场规模

Global Endoscopic Vessel Harvesting Systems Market Size By Product, By Usability, By Vessel-Type, By Application, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

内视镜血管采集系统的市场规模及预测

2024 年内视镜血管采集系统市场规模价值 4,802.8 亿美元，预计到 2032 年将达到 6,422.8 亿美元，预测期内（2026-2032 年）的复合年增长率为 3.70%。

内视镜血管采集系统市场驱动因素

内视镜血管采集系统市场的市场驱动因素可能受到多种因素的影响，其中包括：

心血管疾病发生率不断上升。内视镜血管采集装置在世界各地越来越受欢迎，部分原因是心血管疾病的发生率不断上升。冠状动脉绕道手术手术（CABG）在很大程度上依赖这些系统来治疗冠状动脉疾病。

内视镜方法的改进：随着内视镜方法和技术的不断改进，内视镜血管采集如今更加安全、创伤更小、更有效。这促使医护人员开始使用内视镜血管采集技术。

微创手术：微创手术技术因其许多优势，包括住院时间短、恢復更快、术后併发症更少，越来越受到病人和医师的青睐。用于血管采集的内视镜系统使心血管手术的微创操作更加便捷。随着全球人口老化，需要接受心血管手术的人数也增加。内视镜血管采集是创伤性最小的手术之一，尤其有利于併发症较多的老年患者。

扩大医疗保健基础设施：由于新兴国家医疗保健基础设施的扩大，内视镜血管采集系统市场正在扩大，这使得人们更容易获得尖端手术技术和设备。

成本效益：内视镜取血管手术装置在初始投资后，可以透过减少住院时间、降低併发症发生率并加快患者復原来节省长期成本。医疗机构热衷于投资这些系统的主要原因之一是其成本效益。

监管支援：各个领域对内视镜血管采集系统的有利法规和核准透过确保这些设备的安全性和有效性来推动市场成长，从而增强了医疗保健提供者对其采用的信心。

改进技术：吸引寻求心血管手术最新方法的医疗保健专业人员和患者，旨在提高内视镜血管采集设备的有效性、安全性和易用性的持续技术改进将推动市场扩张。

限制内视镜血管采集系统市场的因素

内视镜取血管手术系统市场面临多种限制与挑战，包括：

昂贵：内视镜血管采集设备的初始和后续操作成本高昂。对于规模较小的医疗机构或融资紧张的机构来说，这可能是一个重大障碍。

报销有限：内视镜取血管手术的费用可能无法完全由保险报销政策覆盖，从而降低了医疗专业人员使用该技术的动机。

技术复杂性：熟练内视镜取血管手术技术可能需要特殊的训练和专业知识。因此，具备相关资格的医疗专业人员可能较少。

问题风险：内视镜取血管手术与其他外科手术一样，有同样的问题风险，包括出血、感染和潜在的组织损伤。这些风险可能会导致一些医护人员选择不使用这些系统。

抵制改变：外科医生可能不愿意使用新的工具和方法，特别是如果他们长期以来一直使用传统方法成功地获取血管。

监管障碍：获得新型内视镜取血管手术设备的监管批准可能耗时且成本高昂，这可能会延迟市场进入并提高生产商的价格。

替代方案的可用性：由于熟悉或感知的有效性，某些外科医生或医疗机构可能更喜欢传统的开放式血管采集方法而不是内视镜系统，这可能会限制采用。

病患选择：由于血管品质、病患解剖结构和潜在疾病的存在，并非所有病患都适合进行内视镜血管采集，从而限制了这些系统的市场。

基础设施需求：一些医疗机构可能没有内视镜取血管手术系统所需的专用设备或手术室，在这种情况下可能需要安装该系统。

长期耐用性和有效性：与更传统的技术相比，内视镜取血管手术的长期耐用性和有效性仍值得怀疑，这可能会影响患者和医疗保健专业人员的采用率。

内视镜血管采集系统市场区隔分析

全球内视镜血管采集系统市场根据产品、可用性、血管类型、应用和地区进行细分。

内视镜血管采集系统市场（依产品划分）

  • EVH 系统
  • 内视镜检查
  • 配件

根据产品，市场细分为EVH系统、内视镜和配件。由于微创血管采集技术的应用日益广泛，且这些产品为一次性产品，EVH系统预计将占据最大的市场占有率，并在整个预测期内保持最快的成长速度。

内视镜血管采集系统市场（依使用者性别划分）

  • 一次性的
  • 可重复使用的

根据可用性，市场分为抛弃式和可重复使用两类。一次性产品占据了大部分市场份额，预计在预测期内将以最快的速度成长，因为一次性设备因其优于可重复使用设备的优势而需求不断增长。

内视镜血管采集系统市场（依血管类型划分）

  • 隐静脉
  • 桡动脉

根据血管类型，市场分为隐静脉和桡动脉。由于隐静脉在伤口併发症、减轻疼痛和美观方面的优势，预计预测期内隐静脉段将以最快的速度增长。

内视镜血管采集系统市场（依应用）

  • 冠状动脉疾病
  • 周边动脉疾病

根据应用，市场分为冠状动脉疾病和周边动脉疾病。由于心血管疾病盛行率上升和老年人口增长，预计冠状动脉疾病领域将在整个预测期内以最快的速度增长。

内视镜血管采集系统市场（按地区）

  • 北美洲
  • 欧洲
  • 亚太地区
  • 其他的
  • 根据区域分析，全球内视镜血管采集系统市场分为北美、欧洲、亚太地区和亚太其他地区。目前，北美占据全球市场主导地位，其次是欧洲，原因是这些地区久坐的生活方式导致冠状动脉疾病发生率高，且各种微创冠状动脉绕道手术（CABG）较为普及。随着亚太国家人均收入的提高和医疗旅游业的蓬勃发展，预计亚太地区的全球市场将快速成长。

主要参与企业

  • 内视镜血管采集系统市场的主要参与企业有：
  • Bausch Health
  • Sun Pharmaceutical Industries Ltd
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd
  • Roche
  • Teva
  • Abbott
  • Johnson & Johnson
  • Novo Nordisk
  • Arena Pharmaceuticals
  • Akrimax Pharmaceuticals.
  • Sorin Group

目录

第一章 内视镜血管采集系统的全球市场介绍

  • 市场概览
  • 研究范围
  • 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

  • 资料探勘
  • 验证
  • 第一手资料
  • 资料来源列表

第四章 内视镜血管采集系统的全球市场展望

  • 概述
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 波特五力模型
  • 价值链分析

第五章全球内视镜血管采集系统市场（按产品）

  • 概述
  • EVH系统
  • 内视镜检查
  • 配件

6. 全球内视镜血管采集系统市场（依使用者性别划分）

  • 概述
  • 一次性的
  • 可重复使用的

7. 全球内视镜血管采集系统市场（依血管类型）

  • 概述
  • 隐静脉
  • 桡动脉

第八章全球内视镜血管采集系统市场（按应用）

  • 概述
  • 冠状动脉疾病
  • 周边动脉疾病

9. 全球内视镜血管采集系统市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 其他的
    • 拉丁美洲
    • 中东和非洲

第十章全球内视镜血管采集系统市场的竞争格局

  • 概述
  • 各公司市场排名
  • 重点发展策略

第十一章 公司简介

  • Getinge
  • MAQUET Holdings
  • Med Europe Srl
  • Terumo
  • Saphena Medical
  • KARL STORZ
  • Cardio Medical
  • Medical Instruments Spa
  • LivaNova

第十二章 附录

  • 相关调查
简介目录
Product Code: 40047

Endoscopic Vessel Harvesting Systems Market Size And Forecast

Endoscopic Vessel Harvesting Systems Market size was valued at USD 480.28 Billion in 2024 and is projected to reach USD 642.28 Billion by 2032, growing at a CAGR of 3.70% during the forecast period 2026-2032.

Endoscopic Vessel Harvesting Systems Market Drivers

The market drivers for the Endoscopic Vessel Harvesting Systems Market can be influenced by various factors. These may include:

Growing Incidence of Cardiovascular disorders: Endoscopic vessel harvesting devices are becoming more and more popular worldwide, partly due to the growing prevalence of cardiovascular disorders. In order to treat coronary artery disease, coronary artery bypass graft (CABG) procedures depend heavily on these systems.

Improvements in Endoscopic methods: Endoscopic vascular harvesting is now safer, less intrusive, and more effective thanks to ongoing improvements in endoscopic methods and technologies. This promotes healthcare providers to use endoscopic vessel harvesting technologies.

Minimally Invasive Surgery: Because of its many advantages, including shorter hospital stays, quicker recovery periods, and fewer post-operative complications, minimally invasive surgical methods are becoming more and more popular among both patients and doctors. Endoscopic systems for harvesting vessels allow for less intrusive techniques in heart surgery.Population Aging: As people get older worldwide, there is a rise in the number of people who need heart surgery. Endoscopic vascular harvesting is one of the less invasive techniques that is especially beneficial for older patients because these patients frequently have comorbidities.

Healthcare Infrastructure expansion: The market for endoscopic vessel harvesting systems is expanding as a result of the expansion of healthcare infrastructure in emerging economies. There is more access to cutting-edge surgical methods and equipment as these areas develop their healthcare infrastructure.

Cost-Effectiveness: Endoscopic vessel harvesting devices can save money in the long run by lowering hospital stays, complication rates, and hastening patient recovery, even after they need an initial investment. One of the main reasons healthcare facilities want to invest in these systems is their cost-effectiveness.

Regulatory Support: By guaranteeing the safety and effectiveness of these devices, favorable regulatory regulations and approvals for endoscopic vessel harvesting systems across different areas foster market growth and increase healthcare providers' trust in implementing them.

Technological improvements: By drawing in medical professionals and patients who are looking for the newest methods in heart surgery, ongoing technological improvements targeted at enhancing the effectiveness, safety, and usability of endoscopic vascular harvesting devices propel market expansion.

Endoscopic Vessel Harvesting Systems Market Restraints

Several factors can act as restraints or challenges for the Endoscopic Vessel Harvesting Systems Market. These may include:

Expensive: Endoscopic vessel harvesting devices can be costly to operate, both initially and continuously. For smaller healthcare facilities or those with tighter funds, this can be a major obstacle.

Limited Reimbursement: Policies for reimbursement might not completely cover the expense of endoscopic vascular harvesting operations, which would discourage healthcare professionals from using them.

Technical Complexity: It may need specific training and expertise to become proficient in the methods needed for endoscopic vascular harvesting. As a result, there may be fewer medical personnel qualified to carry out these treatments.

Risk of problems: Endoscopic vascular harvesting carries the same risks of problems as any surgical surgery, including the possibility of bleeding, infection, and tissue injury. A few healthcare professionals might decide not to use these systems because of these hazards.

Opposition to Change: Surgeons may be reluctant to use new tools or methods, particularly if they have been successfully harvesting vessels using conventional methods for a long time.

Regulatory obstacles: Getting regulatory permission for novel endoscopic vessel harvesting devices can be a time-consuming and expensive procedure that might cause delays in entering the market or raise prices for producers.

Availability of Alternatives: Due to familiarity or perceived efficacy, certain surgeons or healthcare facilities may still favor traditional open vessel harvesting methods over endoscopic systems, which could hold down their adoption.

Patient Selection: Depending on the quality of the vessel, the anatomy of the patient, and any underlying medical issues, not every patient may be a good candidate for endoscopic vascular harvesting. As a result, the market for these systems is limited.

Infrastructure Requirements: Some healthcare facilities may not have the specialized equipment or operating rooms needed for endoscopic vessel harvesting systems, which could make them necessary.

Long-term Durability and Efficacy: Patients' and healthcare professionals' adoption rates may be impacted by doubts over the long-term durability and efficacy of endoscopic vessel harvesting in comparison to conventional techniques.

Endoscopic Vessel Harvesting Systems Market Segmentation Analysis

The Global Endoscopic Vessel Harvesting Systems Market is segmented on the basis of Product, Usability, Vessel-Type, Application, And Geography.

Endoscopic Vessel Harvesting Systems Market, By Product

  • EVH Systems
  • Endoscopes
  • Accessories

Based on Product, The market is bifurcated into EVH Systems, Endoscopes, and Accessories. The EVH systems segment had the biggest market share, and it is predicted to grow at the fastest rate throughout the forecast period. This is due to the increasing use of less invasive techniques for vessel harvesting as well as the disposable nature of these products.

Endoscopic Vessel Harvesting Systems Market, By Usability

  • Disposable
  • Reusable

Based on Usability, The market is bifurcated into Disposable, and Reusable. The disposable segment accounted for the majority of the market. This category is also predicted to grow at the fastest rate over the forecast period, owing to a growing demand for disposable devices over reusable devices due to the benefits they offer.

Endoscopic Vessel Harvesting Systems Market, By Vessel-Type

  • Saphenous Vein
  • Radial Artery

Based on Vessel-Type, The market is bifurcated into Saphenous Vein and Radial Artery. During the forecast period, the saphenous vein segment is predicted to grow at the fastest rate. This is owing to the benefits of the saphenous vein in terms of wound complications, pain reduction, and aesthetics.

Endoscopic Vessel Harvesting Systems Market, By Application

  • Coronary Artery Disease
  • Peripheral Artery Disease

Based on Application, The market is bifurcated into Coronary Artery Disease and Peripheral Artery Disease. Because of the rising prevalence of cardiovascular illnesses and the growing geriatric population, the coronary artery disease sector is predicted to grow at the fastest rate throughout the forecast period.

Endoscopic Vessel Harvesting Systems Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Geography Analysis, The Global Endoscopic Vessel Harvesting Systems Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is now dominating the global market, followed by Europe because of the high incidence of coronary disease owing to sedentary lifestyle patterns adopted in these regions and the availability of all forms of minimally invasive CABG operations. Owing to the rise in per capita income in Asian countries and the growing medical tourism sector, the global market in the Asia Pacific is predicted to rise at a rapid pace.

Key Players

  • The major players in the Endoscopic Vessel Harvesting Systems Market are:
  • Bausch Health
  • Sun Pharmaceutical Industries Ltd
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd
  • Roche
  • Teva
  • Abbott
  • Johnson & Johnson
  • Novo Nordisk
  • Arena Pharmaceuticals
  • Akrimax Pharmaceuticals.
  • Sorin Group

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL ENDOSCOPIC VESSEL HARVESTING SYSTEMS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL ENDOSCOPIC VESSEL HARVESTING SYSTEMS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL ENDOSCOPIC VESSEL HARVESTING SYSTEMS MARKET, BY PRODUCT

  • 5.1 Overview
  • 5.2 EVH Systems
  • 5.3 Endoscopes
  • 5.4 Accessories

6 GLOBAL ENDOSCOPIC VESSEL HARVESTING SYSTEMS MARKET, BY USABILITY

  • 6.1 Overview
  • 6.2 Disposable
  • 6.3 Reusable

7 GLOBAL ENDOSCOPIC VESSEL HARVESTING SYSTEMS MARKET, BY VESSEL-TYPE

  • 7.1 Overview
  • 7.2 Saphenous Vein
  • 7.3 Radial Artery

8 GLOBAL ENDOSCOPIC VESSEL HARVESTING SYSTEMS MARKET, BY APPLICATION

  • 8.1 Overview
  • 8.2 Coronary Artery Disease
  • 8.3 Peripheral Artery Disease

9 GLOBAL ENDOSCOPIC VESSEL HARVESTING SYSTEMS MARKET, BY GEOGRAPHY

  • 9.1 Overview
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 U.K.
    • 9.3.3 France
    • 9.3.4 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Rest of Asia Pacific
  • 9.5 Rest of the World
    • 9.5.1 Latin America
    • 9.5.2 Middle East & Africa

10 GLOBAL ENDOSCOPIC VESSEL HARVESTING SYSTEMS MARKET COMPETITIVE LANDSCAPE

  • 10.1 Overview
  • 10.2 Company Market Ranking
  • 10.3 Key Development Strategies

11 COMPANY PROFILES

  • 11.1 Getinge
    • 11.1.1 Overview
    • 11.1.2 Financial Performance
    • 11.1.3 Product Outlook
    • 11.1.4 Key Developments
  • 11.2 MAQUET Holdings
    • 11.2.1 Overview
    • 11.2.2 Financial Performance
    • 11.2.3 Product Outlook
    • 11.2.4 Key Developments
  • 11.3 Med Europe S.r.l.
    • 11.3.1 Overview
    • 11.3.2 Financial Performance
    • 11.3.3 Product Outlook
    • 11.3.4 Key Developments
  • 11.4 Terumo
    • 11.4.1 Overview
    • 11.4.2 Financial Performance
    • 11.4.3 Product Outlook
    • 11.4.4 Key Developments
  • 11.5 Saphena Medical
    • 11.5.1 Overview
    • 11.5.2 Financial Performance
    • 11.5.3 Product Outlook
    • 11.5.4 Key Developments
  • 11.6 KARL STORZ
    • 11.6.1 Overview
    • 11.6.2 Financial Performance
    • 11.6.3 Product Outlook
    • 11.6.4 Key Developments
  • 11.7 Cardio Medical
    • 11.7.1 Overview
    • 11.7.2 Financial Performance
    • 11.7.3 Product Outlook
    • 11.7.4 Key Developments
  • 11.8 Medical Instruments Spa
    • 11.8.1 Overview
    • 11.8.2 Financial Performance
    • 11.8.3 Product Outlook
    • 11.8.4 Key Developments
  • 11.9 LivaNova
    • 11.9.1 Overview
    • 11.9.2 Financial Performance
    • 11.9.3 Product Outlook
    • 11.9.4 Key Developments

12 Appendix

  • 12.1 Related Research